Cargando…

Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2

BACKGROUND: Prostate cancer ranks as the second most lethal malignancy in the Western world. Previous targeting of prostate-specific antigen and human kallikrein-related peptidase 2, two related enzymes abundantly expressed in prostatic malignancies, with radioimmunoconjugates intended for diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilhelmsson Timmermand, O., Larsson, E., Ulmert, D., Tran, T. A., Strand, SE.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797400/ https://www.ncbi.nlm.nih.gov/pubmed/26983637 http://dx.doi.org/10.1186/s13550-016-0181-z

Ejemplares similares

Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6
por: Timmermand, Oskar Vilhelmsson, et al.
Publicado: (2014)

A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen
por: Vilhelmsson Timmermand, Oskar, et al.
Publicado: (2021)

Preclinical efficacy of hK2 targeted [(177)Lu]hu11B6 for prostate cancer theranostics
por: Timmermand, Oskar Vilhelmsson, et al.
Publicado: (2019)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application
por: Fuhrman-Luck, Ruth A., et al.
Publicado: (2014)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
por: Zani, Marcelo B., et al.
Publicado: (2022)

Humanization, Radiolabeling and Biodistribution Studies of an IgG(1)-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications
por: Strand, Joanna, et al.
Publicado: (2021)

Small-scale dosimetry for alpha particle (241)Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3
por: Mellhammar, Emma, et al.
Publicado: (2022)

Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
por: Du, Jian Ping, et al.
Publicado: (2018)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
por: Stefanini, Ana Carolina B., et al.
Publicado: (2015)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
por: Mella, Cinthia, et al.
Publicado: (2020)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cells
por: Kryza, Thomas, et al.
Publicado: (2017)

The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer
por: Kryza, Thomas, et al.
Publicado: (2019)

Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
por: Kryza, T., et al.
Publicado: (2018)

Erratum: Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer
por: Xu, Chun-Hua, et al.
Publicado: (2014)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
por: Sato, Ai, et al.
Publicado: (2023)

Kallikreins as Biomarkers for Prostate Cancer
por: Hong, Sung Kyu
Publicado: (2014)

Structural basis for the Zn(2+) inhibition of the zymogen-like kallikrein-related peptidase 10
por: Debela, Mekdes, et al.
Publicado: (2016)

Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin
por: Kanada, Kimberly N., et al.
Publicado: (2012)

A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis
por: Du, Jian-Kui, et al.
Publicado: (2021)

Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma
por: Sumiya, Ryusuke, et al.
Publicado: (2023)

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer
por: Sidiropoulos, Konstantinos G., et al.
Publicado: (2014)

A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity
por: Skala, Wolfgang, et al.
Publicado: (2016)

Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity
por: Skala, Wolfgang, et al.
Publicado: (2014)

Aberrant expression of kallikrein‐related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion
por: Delaunay, Tiphaine, et al.
Publicado: (2017)

Hematological Toxicity in Mice after High Activity Injections of (177)Lu-PSMA-617
por: Kristiansson, Amanda, et al.
Publicado: (2022)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
por: Kidana, Kiwami, et al.
Publicado: (2018)

Could Kallikrein-Related Serine Peptidase 3 Be an Early Biomarker of Environmental Exposure in Young Women?
por: Raimondo, Salvatore, et al.
Publicado: (2021)

Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
por: Korsen, Joshua A., et al.
Publicado: (2022)

Kidney Protection with the Radical Scavenger α(1)-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy
por: Kristiansson, Amanda, et al.
Publicado: (2021)

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer
por: Ohlsson, L, et al.
Publicado: (2012)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d867lohl162av717ov430rvum8